Bartoccioni, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 2.084
EU - Europa 1.722
AS - Asia 649
SA - Sud America 118
AF - Africa 20
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.601
Nazione #
US - Stati Uniti d'America 2.063
DE - Germania 332
PL - Polonia 313
SE - Svezia 313
CN - Cina 264
IT - Italia 226
SG - Singapore 219
UA - Ucraina 142
BR - Brasile 104
FR - Francia 93
IE - Irlanda 85
GB - Regno Unito 58
ID - Indonesia 47
FI - Finlandia 45
IN - India 41
RU - Federazione Russa 37
BE - Belgio 20
CA - Canada 17
HK - Hong Kong 17
TR - Turchia 16
NL - Olanda 14
CH - Svizzera 11
CI - Costa d'Avorio 10
AT - Austria 8
VN - Vietnam 6
AU - Australia 5
BD - Bangladesh 5
AR - Argentina 4
EC - Ecuador 4
ES - Italia 4
IQ - Iraq 4
IR - Iran 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CZ - Repubblica Ceca 3
LK - Sri Lanka 3
MA - Marocco 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
GA - Gabon 2
KG - Kirghizistan 2
KR - Corea 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TM - Turkmenistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.601
Città #
Chandler 394
Warsaw 286
Ashburn 264
Singapore 151
Jacksonville 97
San Mateo 88
Dublin 83
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
New York 49
Nanjing 48
Bremen 47
Houston 47
Jakarta 47
Dearborn 44
Chicago 42
Milan 36
North Bergen 36
Boston 34
Fairfield 32
Redwood City 28
Seattle 27
Moscow 25
Kraków 23
Lawrence 23
Los Angeles 23
Princeton 23
Marseille 22
Rome 22
Beijing 19
Des Moines 19
Nanchang 17
Brussels 16
Düsseldorf 14
Izmir 13
Cambridge 12
Hong Kong 12
Washington 11
Abidjan 10
Lancaster 10
São Paulo 10
Helsinki 9
Mountain View 9
Norwalk 9
Nürnberg 9
Shenyang 9
Frankfurt am Main 8
Hebei 8
Tianjin 8
Zurich 8
Buffalo 7
Changsha 7
Chengdu 7
Hangzhou 7
University Park 7
Zhengzhou 7
Boardman 6
Columbus 6
Genoa 6
Jiaxing 6
Turku 6
Charlotte 5
London 5
Munich 5
San Francisco 5
Shanghai 5
Busto Arsizio 4
Falls Church 4
Hefei 4
Naples 4
Oslo 4
Philadelphia 4
Renton 4
Salvador 4
Santa Clara 4
Amsterdam 3
Atlanta 3
Baltimore 3
Belo Horizonte 3
Changchun 3
Chennai 3
Colombo 3
Council Bluffs 3
Edinburgh 3
Fuzhou 3
Gallup 3
Gunzenhausen 3
Kunming 3
Lachine 3
Montreal 3
Nuremberg 3
Ottawa 3
Rabat 3
Stockholm 3
Tirana 3
Toronto 3
Trieste 3
Vienna 3
Totale 2.726
Nome #
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 298
Age-Related Sarcopenia: Diabetes of the Muscle? 269
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 183
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 162
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 146
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 145
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 144
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 140
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 129
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 127
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 125
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 123
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 120
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 116
A Genome-wide Association Study of Myasthenia Gravis 113
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 112
Anti-AChR-negative myasthenia gravis: clinical and immunological features 109
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 103
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 101
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 97
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 96
Response to therapy in myasthenia gravis with anti-MuSK antibody 96
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 91
BAFF serum levels in myasthenia gravis: effects of therapy 89
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 89
Skeletal muscle cells: from local inflammatory response to active immunity 88
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 88
Myasthenia gravis with antibodies to MuSK: an update 86
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 83
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 82
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 80
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 73
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 73
Early-onset myasthenia gravis: clinical characteristics and response to therapy 67
Myasthenia gravis and associated autoimmune diseases 65
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 63
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 62
IL-6, monocyte infiltration and parenchymal cells 62
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 57
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 57
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 55
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 48
Why Does an I.M. Immunization Work? 46
Immune-inflammatory response changes in patients with major depressive disorder 42
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 33
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 28
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 22
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies 6
Totale 4.689
Categoria #
all - tutte 19.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 0 0 0 0 0 0 70 31
2020/2021373 40 38 3 36 79 22 34 9 45 10 47 10
2021/2022461 34 35 11 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024599 16 134 24 43 32 78 37 50 10 20 68 87
2024/2025807 26 54 80 19 77 19 28 68 205 76 155 0
Totale 4.689